PHF8
protein-codingPHD finger protein 8, the group of Lysine demethylases|PHD finger proteins
Gene summary
The protein encoded by this gene is a histone lysine demethylase that preferentially acts on histones in the monomethyl or dimethyl states. The encoded protein requires Fe(2+) ion, 2-oxoglutarate, and oxygen for its catalytic activity. The protein has an N-terminal PHD finger and a central Jumonji C domain. This gene is thought to function as a transcription activator. Defects in this gene are a cause of syndromic X-linked Siderius type intellectual disability (MRXSSD) and over-expression of this gene is associated with several forms of cancer. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2017]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~112.3 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: XL
Disease ID:MONDO:0010286
Submitter: ClinGen
*PHF8* is located on chromosome Xp11.22 and encodes a histone lysine demethylase that plays a role in the regulation of gene expression. *PHF8* was first reported in relation to syndromic X-linked intellectual disability, Siderius type in 2005 (Laumonnier et al., PMID: 16199551) in the family reported by Siderius et al. (1999, PMID: 10398231) and in another family with similar features. Affected males typically have developmental delay with speech delay, intellectual disability, and craniofacial dysmorphism, which can include cleft lip/palate, long face, microcephaly, hypertelorism, broad nasal bridge, retrognathia, and low-set ears. Female carriers are unaffected. Nine variants (nonsense, frameshift, splice, and missense) that have been reported in nine probands in six publications (PMIDs: 16199551, 17594395, 17661819, 25167861, 26633542, 29276005) are included in this curation. Variants in this gene segregated with disease in three additional family members. The mechanism of pathogenicity is loss of function. This gene-disease relationship is also supported by mouse and zebrafish models, protein interaction, and functional alterations in non-patient cells. In summary, there is definitive evidence supporting the relationship between *PHF8* and syndromic X-linked intellectual disability, Siderius type. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on November 7, 2018 (SOP Version 6). As of February 2026, this record underwent administrative updates to update scoring to be consistent with SOP Version 12. No new evidence was added and the classification did not change.
Inheritance Pattern: XL
Disease ID:MONDO:0010286
Submitter: PanelApp Australia
Inheritance Pattern: XL
Disease ID:MONDO:0010286
Submitter: Orphanet
Inheritance Pattern: XL
Disease ID:MONDO:0010286
Submitter: G2P
Inheritance Pattern: XL
Disease ID:MONDO:0010286
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Musculoskeletal; Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to PHF8 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_015107.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 12 | 57 | 2 | 71 | ||
| missense | 1 | 1 | 212 | 18 | 232 | |
| nonsense | 4 | 7 | 7 | 18 | ||
| start loss | 0 | |||||
| frameshift | 9 | 3 | 1 | 13 | ||
| splice donor/acceptor (+/-2bp) | 1 | 8 | 18 | 27 | ||
| Total | 15 | 19 | 250 | 75 | 2 | 361 |
Highest pathogenic variant AF is 0.00000836263
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_055922.1 | 21 | MANE Select | |
| Ensembl | ENSP00000338868.6 | 21 | MANE Select | |
| RefSeq | NP_001171825.1 | 22 | Standard | |
| RefSeq | NP_001171826.1 | 21 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| phf8 | Danio rerio | Structure: pharyngeal arch 1 Quality: decreased size abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Ectoderm Differentiation
- HDMs demethylate histones
- Chromatin modifying enzymes
- Condensation of Prophase Chromosomes
- Chromatin organization
Biological Process
- G1/S transition of mitotic cell cycle
- brain development
- histone H3-K9 demethylation
- histone H4-K20 demethylation
- positive regulation of transcription, DNA-templated
Molecular Function
- chromatin binding
- iron ion binding
- protein binding
- zinc ion binding
- 2-oxoglutarate-dependent dioxygenase activity
Cellular Component
- nucleus
- nucleoplasm
- nucleolus
- nuclear membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000357988
- Coding exons
- 22
- Length
- 112283
- Individuals with no LoFs
- 125738
- Homozygous LoFs
- 1
- Heterozygous LoFs
- 6
- Defined
- 125745
- p
- 0.0000278
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 3.98 | 199 | 431 | 0.461 | 0.0000347 | 6924 |
| Missense (PolyPhen) | 13 | 122.65 | 0.106 | 2206 | ||
| Synonymous | 0.430 | 164 | 171 | 0.958 | 0.0000138 | 2097 |
| Loss of Function | 5.13 | 5 | 40.0 | 0.125 | 0.00000323 | 638 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.000076 | 0.000062 | rare |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.000072 | 0.000054 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.000049 | 0.000035 | rare |
| South Asian | 0.000058 | 0.000033 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Histone lysine demethylase with selectivity for the di- and monomethyl states that plays a key role cell cycle progression, rDNA transcription and brain development. Demethylates mono- and dimethylated histone H3 'Lys-9' residue (H3K9Me1 and H3K9Me2), dimethylated H3 'Lys-27' (H3K27Me2) and monomethylated histone H4 'Lys-20' residue (H4K20Me1). Acts as a transcription activator as H3K9Me1, H3K9Me2, H3K27Me2 and H4K20Me1 are epigenetic repressive marks. Involved in cell cycle progression by being required to control G1-S transition. Acts as a coactivator of rDNA transcription, by activating polymerase I (pol I) mediated transcription of rRNA genes. Required for brain development, probably by regulating expression of neuron-specific genes. Only has activity toward H4K20Me1 when nucleosome is used as a substrate and when not histone octamer is used as substrate. May also have weak activity toward dimethylated H3 'Lys-36' (H3K36Me2), however, the relevance of this result remains unsure in vivo. Specifically binds trimethylated 'Lys-4' of histone H3 (H3K4me3), affecting histone demethylase specificity: has weak activity toward H3K9Me2 in absence of H3K4me3, while it has high activity toward H3K9me2 when binding H3K4me3. {ECO:0000269|PubMed:19843542, ECO:0000269|PubMed:20023638, ECO:0000269|PubMed:20101266, ECO:0000269|PubMed:20208542, ECO:0000269|PubMed:20346720, ECO:0000269|PubMed:20421419, ECO:0000269|PubMed:20531378, ECO:0000269|PubMed:20548336, ECO:0000269|PubMed:20622853, ECO:0000269|PubMed:20622854}.;
- Disease
- DISEASE: Mental retardation, X-linked, syndromic, Siderius type (MRXSSD) [MIM:300263]: A syndrome characterized by mild to borderline mental retardation with or without cleft lip/cleft palate. {ECO:0000269|PubMed:16199551, ECO:0000269|PubMed:17661819, ECO:0000269|PubMed:20101266, ECO:0000269|PubMed:20208542, ECO:0000269|PubMed:20346720, ECO:0000269|PubMed:20421419, ECO:0000269|PubMed:20548336, ECO:0000269|PubMed:20622853, ECO:0000269|PubMed:20622854}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.101
Intolerance Scores
- LoFtool
- 0.352
- RVIS EVS
- -0.03
- RVIS percentile EVS
- 51.92
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- S
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.183
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |